Sofinnova Industrial Biotech I has held a final close at €125 million. Despite missing its original target of €150 million, it is the largest European fund dedicated to the sustainable transition of the chemical industry in Europe and North America.
Sofinnova Partners raises €125m
The European venture capital firm closes largest European industrial biotech fund.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: